|Bid||59.00 x 900|
|Ask||58.96 x 900|
|Day's range||56.57 - 66.27|
|52-week range||41.17 - 107.79|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||126.02|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Third-quarter earnings were positive, but the stock market is focused on the impending end of lock-up agreements.
Silvergate stock started off the year priced at $76 and is now flying at nearly $215 a share. OptimizeRx is right there with it, shares of the telehealth specialist were selling for $33 back in January but now stand at $90. Silvergate has a $5.5 billion market cap and OptimizeRx is at $1.6 billion.
Doximity (NASDAQ: DOCS) has been an impressive growth story so far, with more than 80% of physicians in the United States on the platform. Danny Vena: This is a company called Doximity, ticker D-O-C-S. Now, Doximity has been called the LinkedIn for doctors, but that really sells the company far short of what it does. Consider in a doctor's office, they need tools where they can securely coordinate their patient care, they want to conduct virtual patient visits.